EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study

Clinical trial NCT03877848 · COMPLETED

Trial details

NCT number: NCT03877848
Sponsor: Medinol Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Coronary Stenosis

Start date: 2019-05-06
Primary completion: 2021-06-10
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.